Cargando…

Current and Future Drug and Device Therapies for Pediatric Heart Failure Patients: Potential Lessons from Adult Trials

This review discusses the potential drug and device therapies for pediatric heart failure (HF) due to reduced systolic function. It is important to realize that most drugs that are used in pediatric HF are extrapolated from adult cardiology practices or consensus guidelines based on expert opinion r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Das, Bibhuti B., Moskowitz, William B., Butler, Javed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143500/ https://www.ncbi.nlm.nih.gov/pubmed/33922085 http://dx.doi.org/10.3390/children8050322

Ejemplares similares

Current State of Pediatric Heart Failure
por: Das, Bibhuti B.
Publicado: (2018)

Posterior reversible encephalopathy syndrome in a pediatric heart transplant recipient with coarctation of aorta
por: Das, Bibhuti B., et al.
Publicado: (2022)

Pediatric Heart Failure: Current State and Future Possibilities
por: Rossano, Joseph W., et al.
Publicado: (2015)

Patiromer use in patients with heart failure: lessons and clinical considerations from the DIAMOND trial
por: Butler, Javed, et al.
Publicado: (2022)

Epigenetic Therapies for Heart Failure: Current Insights and Future Potential
por: Napoli, Claudio, et al.
Publicado: (2021)

SGLT-2 Inhibitors in Heart Failure: A Review of Current Evidence
por: Talha, Khawaja M., et al.
Publicado: (2023)

Glucocentric Drugs in Cardiovascular Disease Protection and Heart Failure
por: Talha, Khawaja M., et al.
Publicado: (2022)

Primary Prevention of Heart Failure
por: Butler, Javed
Publicado: (2012)

Non‐insulin antihyperglycaemic drugs and heart failure: an overview of current evidence from randomized controlled trials
por: Savarese, Gianluigi, et al.
Publicado: (2020)

Technology and Heart Failure Therapeutics (THT2022): A Glimpse Into the Future of Devices and Novel Therapies for Heart Failure
por: Burkhoff, Daniel, et al.
Publicado: (2022)

The current and future burden of heart failure in Portugal
por: Gouveia, Miguel, et al.
Publicado: (2019)

Current and future use of neuromodulation in heart failure( )
por: Duncker, David, et al.
Publicado: (2022)

Pediatric ventricular assist devices: current challenges and future prospects
por: Burki, Sarah, et al.
Publicado: (2017)

Heart Failure
por: Giamouzis, Gregory, et al.
Publicado: (2011)

Drugs that slow the progression of diabetic kidney disease: are renoprotective effects attenuated in heart failure?
por: Packer, Milton, et al.
Publicado: (2023)

Diagnosis and Management of Cancer Treatment-Related Cardiac Dysfunction and Heart Failure in Children
por: Hegazy, Mohamed, et al.
Publicado: (2023)

Current state-of-the-art of device therapy for advanced heart failure
por: Lee, Lawrence S., et al.
Publicado: (2014)

Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far?
por: Das, Bibhuti B., et al.
Publicado: (2021)

Maternal Heart Failure
por: Bright, Rachel A., et al.
Publicado: (2021)

Selenium, Selenoproteins, and Heart Failure: Current Knowledge and Future Perspective
por: Al-Mubarak, Ali A., et al.
Publicado: (2021)

New perspectives and future directions in the treatment of heart failure
por: Pellicori, Pierpaolo, et al.
Publicado: (2019)

Growing Evidence Linking Microvascular Dysfunction With Heart Failure With Preserved Ejection Fraction
por: Giamouzis, Gregory, et al.
Publicado: (2016)

Heart Failure 2012
por: Giamouzis, Gregory, et al.
Publicado: (2012)

Recent and Upcoming Drug Therapies for Pediatric Heart Failure
por: Loss, Karla L., et al.
Publicado: (2021)

Neuromodulation Therapy in Heart Failure: Combined Use of Drugs and Devices
por: Sobowale, Christopher O., et al.
Publicado: (2020)

Clinical Pathways Guided by Remotely Monitoring Cardiac Device Data: The Future of Device Heart Failure Management?
por: Taylor, Joanne K, et al.
Publicado: (2023)

Current and emerging drug targets in heart failure treatment
por: Ghionzoli, Nicolò, et al.
Publicado: (2021)

Recognizing the Significance of Outpatient Worsening Heart Failure
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2020)

Targeting Mitochondrial Function in Heart Failure: Makes Sense But Will it Work?
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2019)

Drug development in pediatric psychiatry: current status, future trends
por: March, John S, et al.
Publicado: (2012)

Heart failure with preserved ejection fraction: current status and challenges for the future
por: van der Velden, J., et al.
Publicado: (2016)

Heart Failure in the Middle East Arab Countries: Current and Future Perspectives
por: Elasfar, Abdelfatah A., et al.
Publicado: (2020)

Obstructive Sleep Apnea in Heart Failure: Current Knowledge and Future Directions
por: Javaheri, Shahrokh, et al.
Publicado: (2022)

Current status of outpatient heart failure management in Egypt and recommendations for the future
por: Hassanein, Mahmoud, et al.
Publicado: (2023)

Breakthroughs in the treatment of heart failure with mildly reduced and preserved ejection fraction
por: Talha, Khawaja M., et al.
Publicado: (2022)

The Limitations of Symptom-based Heart Failure Management
por: Papadimitriou, Lampros, et al.
Publicado: (2019)

Heart Failure Treatment by Device
por: Bayés-Genis, Antoni
Publicado: (2020)

Neuromodulation devices for heart failure( )
por: Dusi, Veronica, et al.
Publicado: (2022)

Heart Failure in Pregnancy: A Problem Hiding in Plain Sight
por: Stergiopoulos, Kathleen, et al.
Publicado: (2019)

Hydrogen Sulfide as a Potential Therapy for Heart Failure—Past, Present, and Future
por: LaPenna, Kyle B., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tua2e0rgatbufanc4qb4qu0200